158 related articles for article (PubMed ID: 31073273)
1. Pre-treatment loss to follow-up and treatment delay among bacteriologically-confirmed tuberculosis patients diagnosed in Mandalay Region, Myanmar.
Htwe KK; Kyaw NTT; Kumar AMV; Kyaw KWY; Oo MM; Thwin T; Saw S; Aung ST
Trop Med Health; 2019; 47():30. PubMed ID: 31073273
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment loss to follow-up of tuberculosis patients in Chennai, India: a cohort study with implications for health systems strengthening.
Thomas BE; Subbaraman R; Sellappan S; Suresh C; Lavanya J; Lincy S; Raja AL; Javeed B; Kokila S; Arumugam S; Swaminathan S; Mayer KH
BMC Infect Dis; 2018 Mar; 18(1):142. PubMed ID: 29587651
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment loss to follow-up in adults with pulmonary TB in Kenya.
Mulaku MN; Ochodo E; Young T; Steingart KR
Public Health Action; 2024 Mar; 14(1):34-39. PubMed ID: 38798784
[TBL] [Abstract][Full Text] [Related]
4. Bacteriologically confirmed pulmonary tuberculosis patients: Loss to follow-up, death and delay before treatment initiation in Bulawayo, Zimbabwe from 2012-2016.
Mugauri H; Shewade HD; Dlodlo RA; Hove S; Sibanda E
Int J Infect Dis; 2018 Nov; 76():6-13. PubMed ID: 30030177
[TBL] [Abstract][Full Text] [Related]
5. Indicators to Ensure Treatment Initiation of All Diagnosed Sputum Positive Pulmonary Tuberculosis Patients under Tuberculosis Control Programme in India.
Jayabal L; Frederick A; Mehendale S; Banurekha V
Indian J Community Med; 2017; 42(4):238-241. PubMed ID: 29184327
[TBL] [Abstract][Full Text] [Related]
6. Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?
Htet KKK; Soe KT; Kumar AMV; Saw S; Win Maung HM; Myint Z; Khine TMM; Aung ST
Int J Tuberc Lung Dis; 2018 Apr; 22(4):385-392. PubMed ID: 29562985
[TBL] [Abstract][Full Text] [Related]
7. Effect of mobile voice calls on treatment initiation among patients diagnosed with tuberculosis in a tertiary care hospital of Puducherry: A randomized controlled trial.
Majella MG; Thekkur P; Kumar AM; Chinnakali P; Saka VK; Roy G
J Postgrad Med; 2021; 67(4):205-212. PubMed ID: 34169923
[TBL] [Abstract][Full Text] [Related]
8. National scale-up of tuberculosis-human immunodeficiency virus collaborative activities in Myanmar from 2005 to 2016 and tuberculosis treatment outcomes for patients with human immunodeficiency virus-positive tuberculosis in the Mandalay Region in 2015.
Theingi P; Harries AD; Wai KT; Shewade HD; Saw S; Win T; Thein S; Kyi MS; Nyunt Oo H; Aung ST
Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):402-409. PubMed ID: 29361150
[TBL] [Abstract][Full Text] [Related]
9. Does pre-diagnostic loss to follow-up among presumptive TB patients differ by type of health facility? An operational research from Hwange, Zimbabwe in 2017.
Padingani M; Kumar A; Tripathy JP; Masuka N; Khumalo S
Pan Afr Med J; 2018; 31():196. PubMed ID: 31086640
[TBL] [Abstract][Full Text] [Related]
10. Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.
Cox H; Dickson-Hall L; Ndjeka N; Van't Hoog A; Grant A; Cobelens F; Stevens W; Nicol M
PLoS Med; 2017 Feb; 14(2):e1002238. PubMed ID: 28222095
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment lost to follow-up tuberculosis patients, Chongwe, Zambia, 2017: a retrospective cohort study.
Chilembo M; Oguri S; Matsuoka Y; Ota M; Musiankuni P; Kabungo J
Public Health Action; 2020 Mar; 10(1):21-26. PubMed ID: 32368520
[TBL] [Abstract][Full Text] [Related]
12. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
13. Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.
Cox HS; Mbhele S; Mohess N; Whitelaw A; Muller O; Zemanay W; Little F; Azevedo V; Simpson J; Boehme CC; Nicol MP
PLoS Med; 2014 Nov; 11(11):e1001760. PubMed ID: 25423041
[TBL] [Abstract][Full Text] [Related]
14. Understanding pretreatment loss to follow-up of tuberculosis patients: an explanatory qualitative study in Chennai, India.
Thomas BE; Suresh C; Lavanya J; Lindsley MM; Galivanche AT; Sellappan S; Ovung S; Aravind A; Lincy S; Raja AL; Kokila S; Javeed B; Arumugam S; Mayer KH; Swaminathan S; Subbaraman R
BMJ Glob Health; 2020; 5(2):e001974. PubMed ID: 32181000
[TBL] [Abstract][Full Text] [Related]
15. [Tuberculosis in Asia].
Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
[TBL] [Abstract][Full Text] [Related]
17. Time delay and associated mortality from negative smear to positive Xpert MTB/RIF test among TB/HIV patients: a retrospective study.
Lisboa M; Fronteira I; Colove E; Nhamonga M; Martins MDRO
BMC Infect Dis; 2019 Jan; 19(1):18. PubMed ID: 30616533
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Xpert
Myo K; Zaw M; Swe TL; Kyaw YY; Thwin T; Myo TT; Aye KO; Myint AA
Int J Tuberc Lung Dis; 2018 Sep; 22(9):1051-1055. PubMed ID: 30092871
[TBL] [Abstract][Full Text] [Related]
19. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
[TBL] [Abstract][Full Text] [Related]
20. Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.
Mwansa-Kambafwile J; Maitshotlo B; Black A
PLoS One; 2017; 12(1):e0168659. PubMed ID: 28068347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
